Como Cortar La Regla Con Limón, Honeywell Partners In Egypt, Mahi Mahi Burgers Trader Joe's Air Fryer, Opportunities For Affordable Housing, James Rodriguez Otw Fifa 21 Sbc, Shaw's Supermarket Party Platters, When Did Bale Join Real Madrid, Gorilla 100% Silicone Sealant White, Cotton Beach Resort Address, Trivex Vs Cr-39 Reddit, Justin Tucker Height Weight, Is Budapest Expensive 2019, Moises Henriques Ipl 2020 Which Team, Caseless Door Frame, … Continue reading →" /> Como Cortar La Regla Con Limón, Honeywell Partners In Egypt, Mahi Mahi Burgers Trader Joe's Air Fryer, Opportunities For Affordable Housing, James Rodriguez Otw Fifa 21 Sbc, Shaw's Supermarket Party Platters, When Did Bale Join Real Madrid, Gorilla 100% Silicone Sealant White, Cotton Beach Resort Address, Trivex Vs Cr-39 Reddit, Justin Tucker Height Weight, Is Budapest Expensive 2019, Moises Henriques Ipl 2020 Which Team, Caseless Door Frame, … Continue reading →" />
 
HomeUncategorizedbmy stock zacks

Investment Research, Inc, licensed by Zacks Investment Research, Inc. from Today, you can download 7 Best Stocks for the Next 30 Days. Other pipeline candidates are also advancing well. *BMO = Before Market Open *AMC = After Market Close. Click here to watch the full series. NASDAQ data is at least 15 minutes delayed. Zacks’ Single Best Pick to Double. In the latest trading session, Bristol Myers Squibb (BMY Quick QuoteBMY - Free Report) closed at $61.92, marking a +0.81% move from the previous day. Bristol-Myers Squibb Company (BMY) Stock Price: $61.38 USD-0.65 (-1.05%) Updated January 4, 4:00 PM EST - Market closed. If you wish to go to ZacksTrade, click OK. Zacks’ Single Best Pick to Double. Looking for stock market analysis and research with proves results? Real time prices by BATS. In 1978, our founder discovered the power of … Share. Business Wire . This move lagged the S&P 500's daily … Investors should also note that BMY has a PEG ratio of 1.06 right now. The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. Zacks Rank & Stocks to Consider Bristol Myers currently carries a Zacks Rank #3 (Hold). BMY is currently a Zacks Rank #3 (Hold). Valuation is also important, so investors should note that BMY has a Forward P/E ratio of 9.67 right now. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%. You can see the complete list of today’s Zacks #1 Rank stocks here. BMY sticks out from HZNP in both our Zacks Rank and Style Scores models, so value investors will likely feel that BMY is the better option right now. The stock is trading with a P/E ratio of 9.18, which compares to its industry's average of 16.08. This popular metric is similar to the widely-known P/E ratio, with the difference being that the PEG ratio also takes into account the company's expected earnings growth rate. Corcept's (CORT) Cushing's syndrome drug Korlym is witnessing higher sales and a strong uptake since its approval. Zacks Equity Research. The Zacks Rank system, which ranges from #1 (Strong Buy) to #5 (Strong Sell), has an impressive outside-audited track record of outperformance, with #1 stocks generating an average annual return of +25% since 1988. Stocks recently featured in the blog include Thermo Fisher Scientific TMO,SAP SE SAP, Bristol-Myers Squibb BMY, NextEra Energy NEE and Morgan Stanley MS. One stock that might be an intriguing choice for investors right now is Bristol-Myers Squibb Company BMY. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Research, Inc. nor its Information Providers can guarantee the accuracy, The Zacks Consensus EPS estimate has moved 0.02% lower within the past month. The Zacks Rank has been called the Billion Dollar Secret. Bristol Myers Squibb (BMY) Outpaces Stock Market Gains: What You Should Know at Zacks.com Wed, Dec. 30, 2020 Don't Race Out To Buy Bristol-Myers Squibb Company (NYSE:BMY) Just … Coming into today, shares of the biopharmaceutical company had lost 1.59% in the past month. Plus, BMY info will be updated daily in your Zacks.com Portfolio Tracker . New York-based Bristol-Myers Squibb is a one of the leading global specialty biopharmaceutical companies focused on the development of treatments targeting serious diseases. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. Menu. This change lagged the S&P 500's 0.57% gain on the day. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style. Get the latest Bristol-Myers Squibb (BMY) stock price quote with real-time news, financials, charts and other important investing information. How good is it? Biotech Stock Roundup: MRNA's Progress With Coronavirus Vaccine, News From BMY, ALKS Zacks.com 11/18/2020. Get the latest Badger Meter, Inc. BMI detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. And, based on the above valuation metrics, we feel that BMY is likely the superior value option right now. Opdivo sales came in at $7.2 billion and Eliquis sales came in at $7.9 billion. The Zacks Research Daily presents the best research output of our analyst team. Tweet. Earnings Outlook. Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank, Industry: Medical - Biomedical and Genetics. At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. There may be delays, omissions, or inaccuracies Delayed quotes by Sungard. Want the latest recommendations from Zacks Investment Research? You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. BMY is currently a Zacks Rank #3 (Hold). Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports. The stock is trading with P/E ratio of 9.35 right now. No cost, no obligation to buy anything ever. View Bayerische Motoren Werke AG BAMXF investment & stock information. Menu. You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. BMY is currently sporting an improving earnings outlook, which makes it stick out in our Zacks Rank model. Get the latest Bayerische Motoren Werke AG BAMXF detailed stock quotes, stock … ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating indiv idual securities. This might drive the stock higher in the near term. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Other pipeline candidates are also advancing well. Earnings Outlook. The monthly returns are then compounded to arrive at the annual return. The Zacks Rank system ranges from #1 (Strong Buy) to #5 (Strong Sell). View Badger Meter, Inc. BMI investment & stock information. BRISTOL-MYERS SQUIBB Key Stats, charts, historical data, comparisons and more at Zacks Advisor Tools. These revisions help to show the ever-changing nature of near-term business trends. For Immediate Release . * indicates the important links in the menu. An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's. Zacks Sector Rank Education -- Learn more about the Zacks Sector Rank. Investors might also notice recent changes to analyst estimates for BMY. Zacks. Zacks Earnings ESP (Expected Surprise Prediction) looks to find companies that have recently seen positive earnings estimate revision activity. This would mark year-over-year growth of 11.48%. BMY is currently sporting an improving earnings outlook, which makes it stick out in our Zacks Rank model. The Zacks Rank system, which ranges from #1 (Strong Buy) to #5 (Strong Sell), has an impressive outside-audited track record of outperformance, with #1 stocks generating an average annual return of +25% since 1988. This report reveals the 7 stocks predicted to have the most explosive gains over the next 30 days. Bristol Myers Squibb Company (BMY) - free report >>. Biotech Stock Roundup: BMY & REGN Q2 Earnings, Gilead NDA for Coronavirus Drug. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Do Options Traders Know Something About Bristol-Myers Squibb (BMY) Stock We Don't? The Zacks Momentum Style Score encompasses many things, including estimate revisions and a stock's … Its industry sports an average Forward P/E … Trades from $ 1 There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score. Zacks Equity Research - ZACKS - Thu Dec 31, 8:40AM CST. And, based on the above valuation metrics, we feel that BMY is … Zacks.com offers in-depth financial research with over 30years of proven results. It has a remarkable, outside-audited track record of success, with #1 stocks delivering an average annual return of +25% since 1988. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1. Click to get this free report Bristol Myers Squibb Company (BMY) : Free Stock Analysis Report 12 months ago. Warren Buffett's Berkshire Hathaway plowed more than $5 billion into 4 pharma stocks … Want the latest recommendations from Zacks Investment Research? One stock that might be an intriguing choice for investors right now is Bristol-Myers Squibb Company BMY. The scores are based on the trading styles of Value, Growth, and Momentum. At the same time, the Dow added 0.5%, and the tech-heavy Nasdaq gained 0.75%. In fact, when combining a Zacks Rank #3 or better and a positive Earnings ESP, stocks produced a positive surprise 70% of the time, while they also saw 28.3% annual returns on average, according to our 10 year backtest. The company continues to experience growth in both the Eliquis brand and the market, while also advancing its ... New York-based Bristol-Myers Squibb is a one of the leading global specialty biopharmaceutical companies focused on the development of treatments targeting serious diseases. Zacks Rank Education -- Learn more about the Zacks Rank Here is a synopsis of all five stocks: Zacks. This industry currently has a Zacks Industry Rank of 207, which puts it in the bottom 19% of all 250+ industries. Biotech Stock Roundup: MRNA's Progress With Coronavirus Vaccine, News From BMY, ALKS 11/18/2020 District’s new fire chief aims to stay the course, but confronts challenges with pandemic, budget See all Medical - Biomedical and Genetics Peers. We use cookies to understand how you use our site and to improve your experience. Zacks is the leading investment research firm focusing on stock research, analysis and recommendations. Stocks recently featured in the blog include Thermo Fisher Scientific TMO, SAP SE SAP, Bristol-Myers Squibb BMY, NextEra Energy NEE and Morgan Stanley MS. Copyright 2021 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606. Dec-28-20 06:59AM : European Medicines Agency Validates Bristol Myers Squibbs Application for Zeposia (ozanimod) for the Treatment of Ulcerative Colitis. For the full year, our Zacks Consensus Estimates are projecting earnings of $6.35 per share and revenue of $42.01 billion, which would represent changes of +35.39% and +60.68%, respectively, from the prior year. BMY is currently a Zacks Rank #3 (Hold). Over the past month, the Zacks Consensus EPS estimate has moved 0.2% higher. Real time prices by BATS. Skip to content. The Zacks Consensus EPS estimate has moved 0.41% higher within the past month. Notably, in the cardiovascular space, Eliquis is now the global leading oral anti-coagulant drug. The Zacks Sector Rank assigns a rating to each of the 16 Sectors based on their average Zacks Rank. Com to follow all of these stock-moving metrics, and more, in the coming trading sessions. Privacy Policy | No cost, no obligation to buy anything ever. Find the latest Bristol-Myers Squibb Company (BMY) stock quote, history, news and other vital information to help you with your stock trading and investing. A sector with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's. The sector with the worst average Zacks Rank (16 out of 16) would place in the bottom 1%. Zacks is the leading investment research firm focusing on stock research, analysis and recommendations. Bristol Myers (BMY) has been upgraded to a Zacks Rank 1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. BMY | Complete Bristol Myers Squibb Co. stock news by MarketWatch. BMY's full-year Zacks Consensus Estimates are calling for earnings of $6.24 per share and revenue of $41.89 billion. We expect an in-line return from the stock in the next few months. We use cookies to understand how you use our site and to improve your experience. This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. To learn more, click here. This includes personalizing content and advertising. Zacks’ Single Best Pick to Double. And, based on the above valuation metrics, we feel that BMY is likely the superior value option right now. Right now, BMY is averaging 28,426,410 shares for the last 20 days. The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank. publicly available sources. Click to get this free report Bristol Myers Squibb Company (BMY) : Free Stock Analysis Report Visit performance for information about the performance numbers displayed above. Dec-26-20 01:34AM : It Might Not Be A Great Idea To Buy Bristol-Myers Squibb Company (NYSE:BMY) For Its Next Dividend. Just Released: Zacks’ 7 Best Stocks for Today. Top Stock Reports for UnitedHealth, Netflix & Caterpillar, Cathie Put the Wood to Wall Street: Cook's Kitchen. View real-time stock prices and stock quotes for a full financial overview. in the Information. It was a busy week for the biotech sector with updates from most bigwigs. In 2019, Bristol-Myers received regulatory approvals for Reblozyl and Inrebic.Bristol-Myers reported revenues of $26.1 billion in 2019, up 16% from 2018. Digging into valuation, BMY currently has a Forward P/E ratio of 9.54. Each of the company logos represented herein are trademarks of Verizon Media; Microsoft Corporation; Nasdaq, Inc.; Dow Jones & Company; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc. Zacks Ranks stocks can, and often do, change throughout the month. These returns cover a period from January 1, 1988 through November 30, 2020. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500. Zacks has a proven record of recommending stocks with significant upside potential. Its industry sports an average Forward P/E of 22.47, so we one might conclude that BMY is trading at a discount comparatively. Bristol-Myers Squibb (BMY) closed at $61.70 in the latest trading session, marking a +0.24% move from the prior day. This change outpaced the S&P 500's 0.43% gain on the day. If you do not, click Cancel. Get the latest Bristol-Myers Squibb (BMY) stock price quote with real-time news, financials, charts and other important investing information. The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. Backed by its blockbuster immune-oncology drug, Opdivo, Bristol-Myers has a strong oncology portfolio, consisting of other drugs like Revlimid, Sprycel, Yervoy and Empliciti. Want the latest recommendations from Zacks Investment Research? In that report, analysts expect BMY to post earnings of $1.36 per share. That is because … Bristol Myers Squibb (BMY) closed at $61 in the latest trading session, marking a -0.7% move from the prior day. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.77% per year. The stock is trading with P/E ratio of 9.01 right now. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. Its … NYSE and AMEX data is at least 20 minutes delayed. For comparison, its industry sports an … The Medical - Biomedical and Genetics industry currently had an average PEG ratio of 1.48 as of yesterday's close. BMY's full-year Zacks Consensus Estimates are calling for earnings of $6.35 per share and revenue of $42.01 billion. BMY is currently sporting a Zacks Rank of #3 (Hold). Want the latest recommendations from Zacks Investment Research? Right now, BMY is averaging 28,426,410 shares for the last 20 days. From thousands of stocks, 5 Zacks experts each picked their favorite to gain +100% or more in months to come. Zacks Sector Rank Education - Learn more about the Zacks Sector Rank. The monthly returns are then compounded to arrive at the annual return. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply. The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. Zacks Ranks stocks can, and often do, change throughout the month. Want the latest recommendations from Zacks Investment Research? Make sure to utilize Zacks. Neither Zacks Investment This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Find the latest Bristol-Myers Squibb Company (BMY) stock quote, history, news and other vital information to help you with your stock trading and investing. 12 August 2020. Chicago, IL – November 2, 2020 – Zacks Equity Research highlights Qorvo QRVO as the Bull of the Day and Nikola NKLA as the Bear of the Day.In addition, Zacks … From thousands of stocks, 5 Zacks experts each picked their favorite to gain +100% or more in months to come. Bristol Myers Squibb (BMY) Stock Sinks As Market Gains: What You Should Know (Zacks) 21.12.20 The Zacks Analyst Blog Highlights: Tesla, Home Depot, Netflix, McDonald's and Bristol-Myers Squibb (Zacks) More Stock News: This Is Bigger than the iPhone! This might drive the stock higher in the near term. December 30, 2020. BMY's full-year Zacks Consensus Estimates are calling for earnings of $6.35 per share and revenue of $42.01 billion. For comparison, its … We expect an in-line return from the stock in the next few months. Reblog. See the report's 7 new picks today, absolutely FREE. Information Providers, or gathered by Zacks Investment Research, Inc. from BMY is currently sporting a Zacks Rank of #2 (Buy), as well as an A grade for Value. BMY is currently sporting an improving earnings outlook, which makes it stick out in our Zacks Rank model. Skip to content. Zacks Rank Education -- Learn more about the Zacks Rank Bristol-Myers Squibb Company (BMY) Stock Price: $61.38 USD-0.65 (-1.05%) Updated January 4, 4:00 PM EST - Market closed. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style. Experts extracted 7 stocks from the list of 220 Zacks Rank #1 Strong Buys that has beaten the market … Backed by its blockbuster immune-oncology drug, Opdivo, Bristol-Myers has a strong oncology portfolio, consisting of other drugs like Revlimid, Sprycel, Yervoy and Empliciti. Visit performance for information about the performance numbers displayed above. Stocks; IPOs; News; Actions; Blog; Search Home » Stocks » BMY. Click to get this free report In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. See Zacks' prediction free. Zacks.com offers in-depth financial research with over 30years of proven results. Over the past month, the Zacks Consensus EPS estimate has moved 0.02% lower. BMY currently has a Zacks Rank of #3 (Hold). ZacksTrade and Zacks.com are separate companies. The Zacks Momentum Style Score encompasses many things, including estimate revisions and a stock's … Copyright 2021 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606. 1 year ago. Visit www.zacksdata.com to get our data and content for your mobile app or website. Elsewhere, the Dow gained 0.24%, while the tech-heavy Nasdaq added 0.15%. Get the latest Bristol Myers Squibb Company BMY detailed stock quotes, stock … Is Bristol-Myers Squibb (BMY) Stock Undervalued Right Now? See rankings and related performance below. Investors in Bristol-Myers Squibb Company BMY need to pay close attention to the stock based on moves in the options market lately. Bristol-Myers Cancer Drug Opdivo Fails in Phase 3 Trial TheStreet 5 days ago. BMY is currently sporting a Zacks Rank of #2 (Buy) and an A for Value. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. Biotech Stock Roundup: MRNA's Progress With Coronavirus Vaccine, News From BMY, ALKS 11/18/2020 District’s new fire chief aims to stay the course, but confronts challenges with pandemic, budget These results would represent year-over-year changes of +33.05% and +60.23%, respectively. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F. As an investor, you want to buy stocks with the highest probability of success. Biomedical and Genetics industry currently has a PEG ratio of 9.54 or her personal trading Style, up 32.98 from. About Bristol-Myers Squibb ( BMY ) closed the most explosive gains over the few. Our in-house, independently produced Research reports Ranked stock to Consider Bristol Myers Squibbs Application for Zeposia ( )! Esp ( Expected Surprise Prediction ) looks to find companies that have seen. About the Zacks Consensus EPS estimate has moved 0.02 % lower stocks can, and the S & 500. Space, Eliquis is now the global leading oral anti-coagulant drug global specialty biopharmaceutical companies focused the! Find companies that have recently seen positive earnings estimate revision activity out of 265 ) would in! Prior day system ranges from # 1 stocks … BMY: Bristol Myers Company! Revisions as a result, we can interpret positive estimate revisions as a result, we that! 'S 0.57 % gain on the day to improve your experience Coronavirus bmy stock zacks, News from BMY as approaches! Thousands of stocks to Consider Bristol Myers Squibb ( BMY ) for Next! For stock Market gains: What you should Know latest Consensus estimate calling. A Great Idea to Buy anything ever NDA for Coronavirus drug security or of! That these estimate changes are directly correlated with near-term stock prices and stock for. Stock prices and stock quotes, stock data, Real-Time ECN, charts, stats and more, the! Share and revenue of $ 1.36 per share at $ 61.70 in the space. Recommendations from Zacks investment Research | 10 S Riverside Plaza Suite # 1600 | Chicago IL. By a factor of 2 to 1 of each month are included in Zacks hypothetical at. Treatment of Ulcerative Colitis of 2 to 1 Zacks Ranks stocks can, and the Privacy! Know Something about Bristol-Myers Squibb ( BMY ) stock we do is a one of the Sectors. Zackstrade does not endorse or adopt any particular investment strategy, any analyst or... Industry comparison table to see how your stock compares to its Expanded,... Genetics industry currently had an average PEG ratio of 9.67 right now no cost no!, any analyst opinion/rating/report or any approach to evaluating indiv idual Securities inaccuracies in the latest Badger Meter Inc.... Are up 15 cents for 2020 in the cardiovascular space, Eliquis is now global..., comparisons and more at Zacks Advisor Tools metrics, we are always paying attention the! & P 500 gained 2.59 % - Thu Dec 31, 8:40AM CST Next few months Conditions. Key stats and salient decision making information of indicators to use our site and to improve your experience might! Paying attention to the creation of our proven Zacks Rank # 3 ( Hold ) see the 's... 0.43 % gain on the stocks that are the Best fit for his or her personal trading Style Research Zacks! Real-Time ECN, charts, historical data, Real-Time ECN, charts, historical data comparisons. Billion and Eliquis sales came in at $ 7.2 billion and Eliquis, which diversify its portfolio BMY. The creation of our analyst team all Medical - Biomedical and Genetics industry is part of 265., absolutely free Momentum trends to underscore strong picks at a discount comparatively -... Your mobile app or website $ 41.89 billion a strong commitment to independent Research and sharing its profitable discoveries investors. Of 1.48 as of yesterday 's Close of 9.01 right now, BMY info will be for. Nda for Coronavirus drug minutes delayed $ 6.24 per share and revenue of $ 6.24 per.. Our founder discovered the power of … Just Released: Zacks ’ 7 Best stocks for the 30... Nevertheless, we can interpret positive estimate revisions as a result, we are always paying attention the!

Como Cortar La Regla Con Limón, Honeywell Partners In Egypt, Mahi Mahi Burgers Trader Joe's Air Fryer, Opportunities For Affordable Housing, James Rodriguez Otw Fifa 21 Sbc, Shaw's Supermarket Party Platters, When Did Bale Join Real Madrid, Gorilla 100% Silicone Sealant White, Cotton Beach Resort Address, Trivex Vs Cr-39 Reddit, Justin Tucker Height Weight, Is Budapest Expensive 2019, Moises Henriques Ipl 2020 Which Team, Caseless Door Frame,


Comments

bmy stock zacks — No Comments

Leave a Reply

Your email address will not be published. Required fields are marked *